Biotech4 days ago
PharmaMar Will Receive 21.1 Million to Build a Plant in Madrid and Research Rare Diseases
Sylentis, part of PharmaMar Group, secured a €21.1M NextGenerationEU grant for its Syoligo project—Spain’s first RNA drug production plant. Located in Getafe, Madrid, it will focus...